Q32 BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$8.91
+0.45%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+8.0%
3 months
-41.3%
6 months
+76.8%
1 year
+222.8%
Year to date
+168.4%
52-week range
$1.93 – $21.38
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$265.2M
P/E
7.8
P/B
2.5
P/S
4.9
Revenue
$53.74M
Net income
$33.79M
Diluted EPS
3.13
Gross margin
100.00%
Net margin
62.90%
Return on equity
76.90%
Total debt
$4.56M
Cash
$106.92M
Free cash flow
-$12.83M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$8.95M | — | — | -$3.08M |
| Mar 31, 2026 | $0 | -$7.61M | — | — | -$6.34M |
| Dec 31, 2025 | $53.74M | $57.73M | 100.00% | 107.40% | $820K |
| Sep 30, 2025 | $0 | -$7.39M | — | — | -$4.23M |
| Jun 30, 2025 | $0 | -$9.49M | — | — | -$10.65M |
| Mar 31, 2025 | $0 | -$11.03M | — | — | -$12.48M |
| Dec 31, 2024 | $0 | -$14.19M | — | — | -$11.43M |
| Sep 30, 2024 | $0 | -$17.6M | — | — | -$19.58M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent QTTB news
All market newsNo ticker-linked stories are in the current archive.